Cargando…

An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS

INTRODUCTION: EQ-5D-3L preference-based value sets are predominately based on hypothetical health states and derived in cross-sectional settings. Therefore, we derived an experience-based value set from a prospective observational study. METHODS: The International Costs and Utilities Related to Oste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svedbom, Axel, Borgstöm, Fredrik, Hernlund, Emma, Alekna, Vidmantas, Bianchi, Maria Luisa, Clark, Patricia, Diaz-Curiel, Manuel, Dimai, Hans Peter, Jürisson, Mikk, Lesnyak, Olga, McCloskey, Eugene, Sanders, Kerrie M., Silverman, Stuart, Tamulaitiene, Marija, Thomas, Thierry, Tosteson, Anna N. A., Jönsson, Bengt, Kanis, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063467/ https://www.ncbi.nlm.nih.gov/pubmed/36495384 http://dx.doi.org/10.1007/s11136-022-03303-y

Ejemplares similares

Incidence and direct hospitalisation costs of hip fractures in Vilnius, capital of Lithuania, in 2010
por: Tamulaitiene, Marija, et al.
Publicado: (2012)

Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS)
por: Lesnyak, Olga, et al.
Publicado: (2020)

Vitamin D Level and Activities of Daily Living in Octogenarians: Cross-Sectional Study
por: Alekna, Vidmantas, et al.
Publicado: (2018)

Reliability and Validity of the Lithuanian Version of CASP-19: A Quality of Life Questionnaire for the Elderly
por: Černovas, Andrejus, et al.
Publicado: (2018)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
por: Hernlund, E., et al.
Publicado: (2013)

Osteoporosis in the European Union: a compendium of country-specific reports
por: Svedbom, A., et al.
Publicado: (2013)

A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
por: Talevski, J., et al.
Publicado: (2022)

Associations between Physical Function, Bone Density, Muscle Mass and Muscle Morphology in Older Men with Sarcopenia: A Pilot Study
por: Mastavičiūtė, Asta, et al.
Publicado: (2021)

Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women
por: Marozik, Pavel M., et al.
Publicado: (2018)

Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis
por: Marozik, Pavel, et al.
Publicado: (2019)

Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan
por: Lesnyak, O, et al.
Publicado: (2020)

A surrogate FRAX model for the Kyrgyz Republic
por: Lesnyak, O., et al.
Publicado: (2020)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
por: Ramanau, H., et al.
Publicado: (2018)

Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS)
por: Abimanyi-Ochom, J., et al.
Publicado: (2015)

Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate
por: Lesnyak, O., et al.
Publicado: (2017)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk
por: Dimai, Hans P., et al.
Publicado: (2022)

Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication
por: Dalén, Johan, et al.
Publicado: (2023)

The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study
por: Jürisson, Mikk, et al.
Publicado: (2017)

Erratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study
por: Jürisson, Mikk, et al.
Publicado: (2017)

FRAX™ and the assessment of fracture probability in men and women from the UK
por: Kanis, J. A., et al.
Publicado: (2008)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Prevalence of chronic conditions and multimorbidity in Estonia: a population-based cross-sectional study
por: Jürisson, Mikk, et al.
Publicado: (2021)

A high incidence of vertebral fracture in women with breast cancer
por: Kanis, J A, et al.
Publicado: (1999)

Osteoporosis in Europe: a compendium of country-specific reports
por: Willers, Carl, et al.
Publicado: (2022)

SCOPE 2021: a new scorecard for osteoporosis in Europe
por: Kanis, John A., et al.
Publicado: (2021)

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
por: O'Rourke, N. P., et al.
Publicado: (1994)

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
por: McCloskey, E. V., et al.
Publicado: (2019)

Physical-mental health comorbidity: A population-based cross-sectional study
por: Jürisson, Mikk, et al.
Publicado: (2021)

SCOPE: a scorecard for osteoporosis in Europe
por: Kanis, J. A., et al.
Publicado: (2013)

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
por: O'Rourke, N. P., et al.
Publicado: (1993)

A systematic review of hip fracture incidence and probability of fracture worldwide
por: Kanis, J. A., et al.
Publicado: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study
por: McCloskey, E. V., et al.
Publicado: (2021)

Thirty years of hip fracture incidence in Austria: is the worst over?
por: Dimai, Hans Peter, et al.
Publicado: (2021)

Temporal changes in access to FRAX® in Thailand between 2010 and 2018
por: Chotiyarnwong, Pojchong, et al.
Publicado: (2019)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Sales EQ
por: Blount, Jeb
Publicado: (2017)

Fragility fractures in Europe: burden, management and opportunities
por: Borgström, Fredrik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngo6feqqkielov11q6e55lbhv4